Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts

Introduction: Tofacitinib is an oral JAK inhibitor indicated for the treatment of rheumatoid arthritis (RA). The efficacy and safety of tofacitinib have been shown in several randomized clinical trials. The study presented here aimed to assess the clinical tolerability and effectiveness of tofacitin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Ruediger B., Hasler, Caroline, Popp, Florian, Mattow, Frederik, Durmisi, Mirsada, Souza, Alexander, Hasler, Paul, Rubbert-Roth, Andrea, Schulze-Koops, Hendrik, von Kempis, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832556/
https://www.ncbi.nlm.nih.gov/pubmed/31561582
http://dx.doi.org/10.3390/jcm8101548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832556/
https://www.ncbi.nlm.nih.gov/pubmed/31561582
http://dx.doi.org/10.3390/jcm8101548

Ejemplares similares